Pimonidazole

Generic Name
Pimonidazole
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C11H18N4O3
CAS Number
70132-50-2
Unique Ingredient Identifier
46JO4D76R2
Background

Pimonidazole is under investigation for the diagnostic of Prostate Cancer and Head and Neck Cancer.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

Recruiting
Conditions
Melanoma
Interventions
Drug: Pimonidazole
First Posted Date
2020-12-08
Last Posted Date
2024-05-07
Lead Sponsor
Yana Najjar
Target Recruit Count
20
Registration Number
NCT04658303
Locations
🇺🇸

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer

First Posted Date
2018-10-24
Last Posted Date
2021-02-08
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT03718650
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

FAZA PET/MRI Sarcoma

Not Applicable
Recruiting
Conditions
Sarcoma
Interventions
Drug: Pimonidazole
Drug: 18F-FAZA
First Posted Date
2018-02-01
Last Posted Date
2023-10-27
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
40
Registration Number
NCT03418818
Locations
🇨🇦

University Health Network, Toronto, Ontario, Canada

Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer

First Posted Date
2017-06-08
Last Posted Date
2024-08-12
Lead Sponsor
Sunnybrook Health Sciences Centre
Target Recruit Count
10
Registration Number
NCT03181035
Locations
🇨🇦

Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Hypoxia Analysis in Head and/or Neck Cancer

Phase 2
Conditions
Head and Neck Cancer
Interventions
Drug: Pimonidazole
First Posted Date
2015-04-10
Last Posted Date
2016-06-17
Lead Sponsor
Marius Gustav Bredell
Target Recruit Count
10
Registration Number
NCT02414048
Locations
🇨🇭

Department of Cranio-, Maxillofacial and Oral Surgery, Zürich, Switzerland

Prostate Hypoxia - TIC

Not Applicable
Active, not recruiting
Conditions
Prostate Cancer
Interventions
Drug: Pimonidazole
First Posted Date
2014-03-24
Last Posted Date
2024-06-18
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
39
Registration Number
NCT02095249
Locations
🇨🇦

University Health Network, Toronto, Ontario, Canada

Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
Drug: Fluvastatin
Drug: Pimonidazole
First Posted Date
2013-11-25
Last Posted Date
2017-10-26
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
33
Registration Number
NCT01992042
Locations
🇨🇦

University Health Network- The Princess Margaret Cancer Centre, Toronto, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy